The medical AI debate needs a failure plan, not a bigger promise
AdvaMed's response to the FDA raises a useful buying question: what happens when a medical AI system is wrong, changes or encounters an unfamiliar case?
THE VITALNEX DOSSIER
AI & healthcare
From useful tools to unanswered questions: a measured view of artificial intelligence in health.
2 stories
Samsung and Lark make access the real connected-care test
The partnership's value depends on who qualifies, how enrollment works and what support remains available after a person closes the app.